Legend Biotech Corp (LEGN) Operating cash flow 2018–2025
Legend Biotech Corp (LEGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$100.2MFY2025 · since FY2018: $307.7M → -$100.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$100.2M | +30.4% |
| FY2024 | -$144.0M | +63.4% |
| FY2023 | -$393.3M | -95.4% |
| FY2022 | -$201.3M | -1.4% |
| FY2021 | -$198.5M | +11.0% |
| FY2020 | -$223.0M | -168.5% |
| FY2019 | -$83.1M | -127.0% |
| FY2018 | $307.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LEGN financial trends
LEGN RevenueLEGN Net incomeLEGN Net marginLEGN Gross profitLEGN Gross marginLEGN Operating incomeLEGN Operating marginLEGN Free cash flowLEGN Capital expendituresLEGN Return on equityLEGN Stock buybacksLEGN Dividends paidLEGN Total assetsLEGN Total liabilitiesLEGN Shareholders’ equityLEGN overview →